World Market for Personalized Medicine Diagnostics

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)

In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry.

The concept of ‘Personalized Medicine’, as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality. Fantastic promises have been made over the years in the press and reports of startup concerns. However, slowly but surely real revenues are appearing, and realistic models for future growth will be seen.

Developments that are linked in the press to ‘personalized medicine’ are many, and can at times be confusing. But there are several discovered biomarkers that are important in diagnostic markets.

Biomarkers discussed in the report include:
Cytochrome P450 and Drug Metabolism
Estrogen Receptor and Progesterone
Receptor Status for Breast Cancer
HER2 Overexpression and Herceptin and Tykerb
Epidermal Growth Factor Receptor (EGFR)
KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer
BRAF Mutations and Cancer Therapy
UGT1A1 Genetic Variants
5-Flurouracil Therapy
PIK3CA Genetic Variation
KIF6 Genetic Variation
ALK Genetic Variation

This is a highly active market. A special focus of the report is the bustle of activity with collaborations between IVD and pharmaceutical companies, as well as IVD companies and CLIA labs. This report profiles scores of such companies operating in this market and estimates and forecasts markets (where there are products on the market) for personalized medicine technologies in the following categories:
Cardiac Markers, immunoassays Cardiac Risk Markers
Cardiac markers, molecular Coagulation, routine Coagulation, molecular Cancer, Tumor Markers Cancer, Molecular Cancer, Tissue-based Psychiatric Disorders Diabetes, BGM Diabetes, HbA1c Microbiology, ID/AST Infectious Diseases, Viral Load (HIV, HCV, HBV)
Infectious Diseases, other Blood Bank Molecular Transplant Tissue Typing Lab Developed Tests

Request for Sample Page                                  More about this Report…

Global Nucleic Acid Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country
2012 Global Endocrine Function Testing Market Outlook: Growth Opportunities and Strategies
2012 Global CA Tumor Markers Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
2012 Global Immunoprotein Testing Market Outlook: Growth Opportunities and Strategies
Advances in Drug-Diagnostic Co-Development
2012 European Microbiology Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
Advances in Imaging Biomarkers: Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements
Advertisements

Tagged: , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: